Deutsch English Français

Contact

EP1378752

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1378752

EP1378752 - METHOD OF QUANTIFYING ANTIGEN EXPRESSION [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 01.05.2015 Database last updated on 19.07.2024
Most recent event Tooltip	01.05.2015	Application deemed to be withdrawn	published on 03.06.2015 [2015/23]
Applicant(s)	For all designated states CHUGAI SEIYAKU KABUSHIKI KAISHA 5-1, Ukima 5-chome Kita-ku Tokyo, 115-8543 / JP
	[N/P]
Former [2004/02]	For all designated states CHUGAI SEIYAKU KABUSHIKI KAISHA 5-1, Ukima 5-chome, Kita-ku Tokyo, 115-8543 / JP
Inventor(s)	01 / Kawai, Shigeto c/o Chugai Seiyaku Kabushiki Kaisha 135, Komakado 1-chome Gotenba-shi, Shizuoka 412-8513 / JP
	02 / Iida, Shinichiro c/o Chugai Seiyaku K.K. 135, Komakado 1-chome Gotenba-shi, Shizuoka 412-8513 / JP
	03 / Koishihara, Yasuo c/o Chugai Seiyaku K.K. 1-9, Kyobashi 2-chome TChuo-ku Tokyo 104-8301 / JP
	[2004/02]
Representative(s)	Harding, Charles Thomas D Young & Co LLP 120 Holborn London EC1N 2DY / GB
	[N/P]
Former [2004/02]	Harding, Charles Thomas D. Young & Co. 21 New Fetter Lane London EC4A 1DA / GB
Application number, filing date	02718571.9	12.04.2002
	[2004/02]
	WO2002JP03703
Priority number, date	JP20010115889	13.04.2001 Original published format: JP 2001115889
	[2004/02]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO02084290
	Date:	24.10.2002
	Language:	EN
	[2002/43]
	Type:	A1 Application with search report
	No.:	EP1378752
	Date:	07.01.2004
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 24.10.2002 takes the place of the publication of the European patent application.
	[2004/02]
Search report(s)	International search report - published on:	JP	24.10.2002
	(Supplementary) European search report - dispatched on:	EP	17.06.2004
Classification	IPC:	G01N33/536, G01N33/574, A61K39/395, C07K16/30	[2004/31]
	CPC:	G01N33/57426 (EP,US); A61P35/00 (EP); A61P35/02 (EP); G01N21/274 (EP,US); G01N21/6428 (EP,US); G01N33/5005 (EP,US); (+) G01N33/582 (EP,US); G01N2800/52 (EP,US); Y10T436/101666 (EP,US); Y10T436/12 (EP,US); Y10T436/13 (EP,US) (-)
	Former IPC [2004/02]	G01N33/536, G01N33/53, G01N33/574, G01N21/64
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/02]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	VERFAHREN ZUR QUANTIFIZIERUNG DER ANTIGENEXPRESSION	[2004/02]
	English:	METHOD OF QUANTIFYING ANTIGEN EXPRESSION	[2004/02]
	French:	PROCEDE PERMETTANT DE QUANTIFIER L'EXPRESSION D'ANTIGENES	[2004/02]
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	13.10.2003	Translation filed
	13.10.2003	National basic fee paid
	13.10.2003	Search fee paid
	13.10.2003	Designation fee(s) paid
	13.10.2003	Examination fee paid
Examination procedure	17.05.2002	Request for preliminary examination filed International Preliminary Examining Authority: JP
	13.10.2003	Examination requested [2004/02]
	27.03.2008	Despatch of a communication from the examining division (Time limit: M06)
	03.10.2008	Reply to a communication from the examining division
	19.01.2011	Cancellation of oral proceeding that was planned for 28.01.2011
	28.01.2011	Date of oral proceedings (cancelled)
	10.02.2011	Despatch of communication that the application is refused, reason: substantive examination {1}
	01.11.2014	Application deemed to be withdrawn, date of legal effect [2015/23]
	16.12.2014	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2015/23]
Appeal following examination	07.04.2011	Appeal received No. T1567/11
	17.06.2011	Statement of grounds filed
	18.03.2015	Result of appeal procedure: the application was deemed to be withdrawn
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.03.2008
Fees paid	Renewal fee
	06.04.2004	Renewal fee patent year 03
	11.04.2005	Renewal fee patent year 04
	17.03.2006	Renewal fee patent year 05
	16.04.2007	Renewal fee patent year 06
	13.03.2008	Renewal fee patent year 07
	15.04.2009	Renewal fee patent year 08
	17.03.2010	Renewal fee patent year 09
	21.04.2011	Renewal fee patent year 10
	15.03.2012	Renewal fee patent year 11
	16.04.2013	Renewal fee patent year 12
	Penalty fee
	Additional fee for renewal fee
	30.04.2014	13 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]EP0960936 (CHUGAI PHARMACEUTICAL CO LTD [JP]) [X] 1-27,35-40 * see pages 36-40; page 19 - page 20; claims 84,86,88 *;
		[X]EP1023906 (CHUGAI PHARMACEUTICAL CO LTD [JP]) [X] 1-27,35-40 * page 3 - page 11; claim 19 *;
		[X]EP1025522 (GIANINNI JO MELINNA [US]) [X] 35-40 * abstract *;
		[X]EP1059533 (CHUGAI PHARMACEUTICAL CO LTD [JP]) [X] 1-27,35-40 * column 25; claim - *;
		[Y] - OZAKI K ET AL, "LOCALIZATION AND IMAGING OF HUMAN PLASMACYTOMA XENOGRAFTS IN SEVERE COMBINED IMMUNODEFICIENCY MICE BY A NEW MURINE MONOCLONAL ANTIBODY, ANTI-HM1.24", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, (1996), vol. 43, ISSN 0022-1007, pages 7 - 15, XP002912306 [Y] 1-27,35-40 * page 7 - page 9 *
		[X] - GOTO T ET AL, "NOVEL MEMBRANE ANTIGEN SELECTIVELY EXPRESSED ON TERMINALLY DIFFERENTIATED HUMAN B CELLS", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, (1994), vol. 84, no. 6, ISSN 0006-4971, pages 1922 - 1930, XP000921004 [X] 1-27,35-40 * page 1922 - page 1924 *
		[X] - OZAKI S ET AL, "IMMUNOTHERAPY OF MULTIPLE MYELOMA WITH A MONOCLONAL ANTIBODY DIRECTED AGAINST A PLASMA CELL-SPECIFIC ANTIEN, HM1.24", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, (1997), vol. 90, no. 8, ISSN 0006-4971, pages 3179 - 3186, XP002912305 [X] 35-40 * page 3180 - page 3185 *
		[Y] - ONO KOICHIRO ET AL, "The humanized anti-HM1.24 antibody effectively kills multiple myeloma cells by human effector cell-mediated cytotoxicity", MOLECULAR IMMUNOLOGY, (199904), vol. 36, no. 6, ISSN 0161-5890, pages 387 - 395, XP002282626 [Y] 1-27,35-40 * page 387 - page 391 * DOI: http://dx.doi.org/10.1016/S0161-5890(99)00029-2
		[Y] - OHTOMA T ET AL, "MOLECULAR CLONING AND CHARCTERIZATION OF A SURFACE ANTIGEN PREFERENTIALLY OVEREXPRESSED ON MULTIPLE MYELOMA CELLS", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (1999), vol. 258, no. 3, ISSN 0006-291X, pages 583 - 591, XP002950705 [Y] 1-27,35-40 * page 583 - page 585 * DOI: http://dx.doi.org/10.1006/bbrc.1999.0683
		[Y] - OZAKI S ET AL, "Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells", BLOOD, W.B.SAUNDERS COMPAGNY, ORLANDO, FL, US, (19990601), vol. 93, no. 11, ISSN 0006-4971, pages 3922 - 3930, XP002214462 [Y] 1-27,35-40 * page 3922 - page 3923 *
	International search	[X]JPH10286088 (CHUGAI PHARMACEUTICAL CO LTD);
		[Y]JPS61223559 (SEKISUI FINE CHEMICAL CO LTD, et al);
		[Y]WO0017395 (CHUGAI PHARMACEUTICAL CO LTD [JP], et al);
		[Y]JPH10155494 (CHUGAI PHARMACEUTICAL CO LTD);
		[A]JPS6336151 (SHOWA DENKO KK)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p